Parkinson’s UK invests in clinical trial of a potential treatment that could protect brain cells Date 2 July 2024
Parkinson's UK invests in first trial of pioneering treatment in people with Parkinson’s Date 1 July 2024
Parkinson's UK invests in developing potential new drug with Acurex Biosciences Date 7 August 2024 We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.
Results from major study of speech and language therapy for Parkinson’s published Date 11 July 2024 The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.
Caption Researcher in a laboratory £100,000 awarded for research looking at new drug target for Parkinson’s Date 26 June 2024 Parkinson's UK is funding researchers to develop a potential set of drugs against a new target for people with Parkinson's.
Caption test samples in tubes Blood test shows promise for identifying Parkinson’s before movement symptoms Date 18 June 2024 Research co-funded by Parkinson’s UK finds a new way to potentially improve diagnosis and monitoring of Parkinson’s.
Parkinson's UK invests in development of potential new drugs to protect brain cells using mitochondria Date 5 June 2024 We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
Caption Photo by Aurore Delsoir Photography Prize for work ensuring patient voice is included in research Date 31 May 2024 A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Awarding nearly £600,000 to support the next leaders in Parkinson's research Date 11 April 2024 Parkinson’s UK has funded two future leaders in Parkinson’s research who are pushing forward our understanding of the early stages and causes of Parkinson’s.
Gut bacteria transplant may improve Parkinson’s movement symptoms Date 8 April 2024 Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson’s, called a faecal microbiota transplant, is safe and may ease motor symptoms.
Results from a phase 2 trial of lixisenatide have been published Date 4 April 2024 Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
New research study shows impact of delirium for people with Parkinson’s in hospital Date 21 March 2024 New research study shows impact of delirium for people with Parkinson’s in hospital